263 related articles for article (PubMed ID: 32104382)
1. Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis.
Chennakesavulu S; Mishra A; Sudheer A; Sowmya C; Suryaprakash Reddy C; Bhargav E
Asian J Pharm Sci; 2018 Jan; 13(1):91-100. PubMed ID: 32104382
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary disposition of budesonide from liposomal dry powder inhaler.
Joshi M; Misra AN
Methods Find Exp Clin Pharmacol; 2001 Dec; 23(10):531-6. PubMed ID: 11957743
[TBL] [Abstract][Full Text] [Related]
3. Liposomal budesonide for dry powder inhaler: preparation and stabilization.
Joshi MR; Misra A
AAPS PharmSciTech; 2001 Nov; 2(4):25. PubMed ID: 14727862
[TBL] [Abstract][Full Text] [Related]
4. Nano-liposomal dry powder inhaler of Amiloride Hydrochloride.
Chougule MB; Padhi BK; Misra A
J Nanosci Nanotechnol; 2006; 6(9-10):3001-9. PubMed ID: 17048511
[TBL] [Abstract][Full Text] [Related]
5. Dry-Powder Inhaler Formulation of Rifampicin: An Improved Targeted Delivery System for Alveolar Tuberculosis.
Rawal T; Kremer L; Halloum I; Butani S
J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):388-398. PubMed ID: 28510480
[TBL] [Abstract][Full Text] [Related]
6. Development of spray dried liposomal dry powder inhaler of Dapsone.
Chougule M; Padhi B; Misra A
AAPS PharmSciTech; 2008; 9(1):47-53. PubMed ID: 18446460
[TBL] [Abstract][Full Text] [Related]
7. Development of liposomal salbutamol sulfate dry powder inhaler formulation.
Huang WH; Yang ZJ; Wu H; Wong YF; Zhao ZZ; Liu L
Biol Pharm Bull; 2010; 33(3):512-7. PubMed ID: 20190418
[TBL] [Abstract][Full Text] [Related]
8. Nano-liposomal dry powder inhaler of tacrolimus: preparation, characterization, and pulmonary pharmacokinetics.
Chougule M; Padhi B; Misra A
Int J Nanomedicine; 2007; 2(4):675-88. PubMed ID: 18203434
[TBL] [Abstract][Full Text] [Related]
9. Novel dry powder inhaler formulation containing antibiotic using combined technology to improve aerodynamic properties.
Ambrus R; Benke E; Farkas Á; Balásházy I; Szabó-Révész P
Eur J Pharm Sci; 2018 Oct; 123():20-27. PubMed ID: 30016647
[TBL] [Abstract][Full Text] [Related]
10. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
[TBL] [Abstract][Full Text] [Related]
11. Development of liposomal amphotericin B dry powder inhaler formulation.
Shah SP; Misra A
Drug Deliv; 2004; 11(4):247-53. PubMed ID: 15371106
[TBL] [Abstract][Full Text] [Related]
12. Liposomal dry powders as aerosols for pulmonary delivery of proteins.
Lu D; Hickey AJ
AAPS PharmSciTech; 2005 Dec; 6(4):E641-8. PubMed ID: 16408866
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of haloperidol-anchored albumin nanoparticles loaded with doxorubicin as dry powder inhaler for pulmonary delivery.
Varshosaz J; Hassanzadeh F; Mardani A; Rostami M
Pharm Dev Technol; 2015 Mar; 20(2):183-96. PubMed ID: 24219091
[TBL] [Abstract][Full Text] [Related]
14. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of βcyclodextrin-based nanosponges loaded with Budesonide for pulmonary delivery.
Salem YY; Hoti G; Sammour RMF; Caldera F; Cecone C; Matencio A; Shahiwala AF; Trotta F
Int J Pharm; 2023 Nov; 647():123529. PubMed ID: 37858636
[TBL] [Abstract][Full Text] [Related]
16. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations.
Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP
Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of Salbutamol Delivered from the Unit Dose Dry Powder Inhaler: Comparison with the Metered Dose Inhaler and Diskus Dry Powder Inhaler.
Moore A; Riddell K; Joshi S; Chan R; Mehta R
J Aerosol Med Pulm Drug Deliv; 2017 Jun; 30(3):164-172. PubMed ID: 28170282
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle-containing lyophilized dry powder inhaler formulations optimized using central composite design with improved aerodynamic parameters and redispersibility.
Akdag Y
Pharm Dev Technol; 2023 Jan; 28(1):124-137. PubMed ID: 36602194
[No Abstract] [Full Text] [Related]
19. Extrinsic lactose fines improve dry powder inhaler formulation performance of a cohesive batch of budesonide via agglomerate formation and consequential co-deposition.
Kinnunen H; Hebbink G; Peters H; Huck D; Makein L; Price R
Int J Pharm; 2015 Jan; 478(1):53-59. PubMed ID: 25448567
[TBL] [Abstract][Full Text] [Related]
20. Lung delivery of nanoliposomal salbutamol sulfate dry powder inhalation for facilitated asthma therapy.
Honmane S; Hajare A; More H; Osmani RAM; Salunkhe S
J Liposome Res; 2019 Dec; 29(4):332-342. PubMed ID: 30296863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
